HeraMED Limited (ASX:HMD)
0.0160
0.00 (0.00%)
Apr 29, 2025, 3:10 PM AEST
HeraMED Company Description
HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States.
It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution.
The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant mothers.
HeraMED Limited was founded in 2011 and is based in Camberwell, Australia.
HeraMED Limited

Country | Australia |
Founded | 2011 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Anoushka Gungadin |
Contact Details
Address: 697 Burke Road Camberwell, 3124 Australia | |
Phone | 61 2 7251 1888 |
Website | hera-med.com |
Stock Details
Ticker Symbol | HMD |
Exchange | Australian Securities Exchange |
Fiscal Year | January - December |
Reporting Currency | AUD |
ISIN Number | AU0000028367 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Anoushka Gungadin | MD, Chief Executive Officer and Director |
Cameron Peter Jones C.A. | Chief Financial Officer and Company Secretary |
Henry Jordan | Head of Investor Relations |
Dr. Arturo Weschler M.D. | C.M.O |